Insight Molecular Diagnostics Inc.

IMDX · Nasdaq · SIC 2835: In Vitro & In Vivo Diagnostic Substances · Market Cap: $0.1B · 58 employees
274
SEC Filings
$4.01
Close 2026-09-02
58
Employees

Business Summary

Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics technology company focused on molecular diagnostic test kits for transplanted organ rejection testing. Its flagship product line, GraftAssure, quantifies donor-derived cell-free DNA (dd-cfDNA) as a biomarker for organ rejection. Products include GraftAssureCore (LDT), GraftAssureIQ (RUO kit), and GraftAssureDx (IVD kit in development). The company operates a CLIA-certified, CAP-accredited lab in Franklin, Tennessee, and also offers oncology assays (DetermaIO, DetermaCNI) and laboratory services.

Latest Stock Quote

IMDX 2026-09-02 $4.01 O:$3.81 H:$4.04 L:$3.71 Vol:0.1M VWAP:$3.9244
origin leaf: null

Next Earnings

expected 2026-12-21

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-262025-12-310001642380-26-000004EDGAR80K words
2025-03-242024-12-310000950170-25-043852EDGAR97K words
2024-04-162023-12-310001493152-24-014720EDGAR83K words
2023-04-122022-12-310001493152-23-012005EDGAR89K words
2022-03-112021-12-310001493152-22-006677EDGAR—
2021-03-192020-12-310001493152-21-006465EDGAR—
2020-03-262019-12-310001493152-20-004738EDGAR—
2019-04-012018-12-310001493152-19-004549EDGAR—
2018-04-022017-12-310001140361-18-016477EDGAR—
2017-02-272016-12-310001140361-17-009369EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-102026-06-300001642380-26-000011EDGAR42K words
2025-11-102025-09-300001193125-25-274266EDGAR46K words
2025-08-112025-06-300000950170-25-106552EDGAR45K words
2025-05-122025-03-310000950170-25-069213EDGAR39K words
2024-11-122024-09-300000950170-24-125365EDGAR45K words
2024-08-082024-06-300001493152-24-030793EDGAR45K words
2024-05-152024-03-310001493152-24-019842EDGAR40K words
2023-11-092023-09-300001493152-23-040121EDGAR40K words
2023-08-102023-06-300001493152-23-027603EDGAR41K words
2023-05-152023-03-310001493152-23-016796EDGAR37K words
2022-11-102022-09-300001493152-22-031415EDGAR—
2022-08-122022-06-300001493152-22-022151EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-210001493152-26-043560EDGAR1K words
2026-08-100001493152-26-036863EDGAR7K words
2026-03-260001493152-26-012915EDGAR8K words
2026-02-260001493152-26-008169EDGAR1K words
2026-02-120001493152-26-006473EDGAR1K words
2026-02-110001493152-26-006117EDGAR0K words
2025-11-100001493152-25-021513EDGAR7K words
2025-10-020001493152-25-016685EDGAR1K words
2025-09-190001493152-25-014240EDGAR1K words
2025-08-110001641172-25-022974EDGAR7K words

274 total filings indexed. 242 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

ACHV — ACHIEVE LIFE SCIENCES, INC. TKNO — Alpha Teknova, Inc. NNNN — Anbio Biotechnology AWHL — Aspira Women's Health Inc. BMRA — BIOMERICA INC BZYR — BURZYNSKI RESEARCH INSTITUTE INC CDIO — Cardio Diagnostics Holdings, Inc. CLDX — Celldex Therapeutics, Inc.

Tags

organ-transplant-rejection-testing oncology-therapy-selection oncology-therapy-monitoring laboratory-services-for-life-sciences-and-biotechnology clia-(clinical-laboratory-improvements-amendment) cap-(college-of-american-pathologists)-accreditation fda-marketing-authorization-(ivd) in-vitro-diagnostic-medical-devices-regulation-(eu-ivdr) moldx-program-(palmetto-gba-mac) local-coverage-determinations-(lcds)

Company Identity

CIK0001642380
TickerIMDX
ExchangeNasdaq
SIC2835: In Vitro & In Vivo Diagnostic Substances
IncorporatedCA
HeadquartersFranklin, Tennessee
Websitehttps://www.imdxinc.com
Listed2015-12-30

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 6af41ae5b90aee8635cf33f71a9ff40a5cf5f8538d5f68807e96d7d86ab71627
parent: 0397d9a4ea21e334011fe5ca2cc810d0aa56258d1ac1ca3983bb086a8c4c8563
content hash: f61dbaadd76bb027ee8dadae49795eb5bb17e5897e56a562dbf55c30cc62b0bb
signed: 2026-09-29T12:01:50.779Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up IMDX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on IMDX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/IMDX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.